LAGUNA HILLS, Calif., March 29, 2016 (GLOBE NEWSWIRE) — Sonendo®, Inc., the developer of a disruptive technology for the endodontic marketplace, announces their attendance at this year’s American Association of Endodontists (AAE) annual meeting in San Francisco.
On Wednesday, April 6th, at 10:45 a.m. PDT in the main exhibit hall, Prashanthi Vandrangi, PhD, MS and Tyler Baker, DDS, MS will be sharing the latest research and clinical results on the GentleWave® System, including biofilm, and bacteria removal and improved patient outcomes. About the presentation Dr. Vandrangi stated, “It is remarkable to see just how much progress we have made in improving patient outcomes by challenging conventional thinking in root canal therapy and leveraging advancements in technology.”
On Thursday, April 7th, at 4:30 p.m. PDT, Dr. Joe Maggio, DDS past president of the AAE, will deliver a presentation titled, Beyond Conventional Canal Disinfection, which will showcase advancements in clinical efficacy achieved with the GentleWave System. Regarding the presentation Dr. Maggio stated, “Only endodontists who are forward-thinking enough to think they can change endodontics are the ones who actually will. This presentation points the way to the future.”
Results achieved by the GentleWave System will be included in eight session and oral poster presentations. In addition, Sonendo will exhibit the GentleWave System at the 2016 AAE annual meeting from April 6 to April 9, at the Moscone Convention Center, Booth # 317.
About Sonendo®
Sonendo, Inc. is a privately-held, venture-backed company developing innovative and disruptive technologies to transform dentistry by Saving Teeth Through Sound Science®. The first commercially available product from Sonendo, the GentleWave® System, available in the US, shows significant improvements in clinical efficacy, and treatment efficiency when compared to conventional root canal techniques1-2. For more information please visit: www.sonendo.com.
1Molina B et al. (2015) J Endod. 41:1701-05. 2Haapasalo M et al. (2014) J Endod. 40:1178-81.
Forward-Looking Statements
This announcement contains forward-looking statements that are based on management’s beliefs, assumptions and expectations and on information currently available to management. All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations with respect to the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. Sonendo does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.
CONTACT: Media Contact: Bob Guyatt Vice President of Marketing 949.766.3636
Source: Medical